A bitter pill! Gland Pharma records biggest fall since listing, hits 52-week low
New Delhi: Shares of dropped 15% during the trading session on Thursday, registering its biggest intra-day loss in more than two years of listing at the bourses following a disappointing Q2 performance. The drug maker, which announced its results for the September 2022 quarter, reported a 20% year-on-year (YoY) decline in consolidated net profit at … Read more